The latest research implicates that the PISK/AKT pathway is involved in radiotherapy resistance in HCC patients, and ablation of PDK1 function might improve radiosensitivity and is associated with deactivated PI3K/AKT/mTOR signaling [43]. This evidence concerns the gene PDK1 and hepatocellular carcinoma.